Growing evidence indicates that low circulating SHBG level is an indicator of adiposity and insulin resistance and therefore SHBG may be a clinically useful biomarker for the early identification of children who at risk to develop obesity-related metabolic disorders (25). The gene discussed is SHBG; the disease is obesity due to melanocortin 4 receptor deficiency.